HBS Women of the Twin Cities with Amy Ronneberg, CEO of NMDP
Join us February 27th from 5-8 pm - arrive by 6 pm as doors lock.
*** RSVP if you plan to attend — no response needed if you cannot. ***
HBS Women of the Twin Cities
Connection + Guest Speaker Event
Thursday Feb 27th 5-8 PM
5 PM chat & connect
6 PM Amy Ronneberg, CEO of NMDP
Q&A to follow and plenty of time to chat, snack, and reconnect.
There will be light appetizers, NA beverages, and wine
Please arrive at 601 Carlson Parkway by 6 PM as the outside doors will lock at that point!
Park in the attached ramp, enter the 601 building and come to the lower level.
About Amy Ronneberg
Amy Ronneberg is the CEO of NMDP, a $750 million international healthcare company that saves lives through cell therapy for blood cancers and disorders. She is also a director at Allina Health, a $5 billion healthcare company, and Actuate Therapeutics (NASDAQ: ACTU), a public biotech company focused on better pancreatic cancer treatment. Previously, Ms. Ronneberg was a director at Magenta Therapeutics (NASDAQ: MGTA), where she was part of the team that led to a successful IPO. She has served on several nonprofit boards including Medical Alley, World Marrow Donor Association and Twin Cities in Motion. Ms. Ronneberg is a faculty member for WBL in HealthCare where she prepares women for board service. She recently completed her Corporate Directorship Certification at Harvard Business School! Not only is the work that NMDP does truly inspiring, Amy herself has been a force for transformation and change within the organization, leading the way to a new business model and culture.
Questions:
Juli@JuliSchmidt.com
612-750-4978